How many weeks will a 10 mL vial of testosterone (200 mg/mL) last when administered at 0.5 mL per week?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of 10mL Testosterone Vial at 0.5mL Weekly Dosing

A 10mL vial of testosterone 200mg/mL will last exactly 20 weeks when administered at 0.5mL per week.

Simple Calculation

This is straightforward mathematics:

  • Total vial volume: 10mL
  • Weekly dose: 0.5mL
  • Duration: 10mL ÷ 0.5mL/week = 20 weeks

Clinical Context

Your weekly dose of 0.5mL delivers 100mg of testosterone per week (0.5mL × 200mg/mL = 100mg). This dosing regimen aligns with established clinical practice:

Dosing Validation

The FDA-approved dosing for testosterone cypionate ranges from 50-400mg every 2-4 weeks for hypogonadal males 1. Your 100mg weekly regimen falls within this approved range and represents a common contemporary approach.

Research supports this dosing frequency: A 2022 comparative study demonstrated that 100mg intramuscular weekly injections provide stable testosterone levels with a significantly lower risk of erythrocytosis (hematocrit >54%) compared to 200mg biweekly dosing—only 1% versus 8% developed elevated hematocrit 2. This suggests the weekly dosing pattern may offer superior safety.

Monitoring Considerations

According to Endocrine Society guidelines, you should have testosterone levels checked 3-6 months after initiation, measured midway between injections for injectable testosterone 3. The target is mid-normal range (400-700 ng/dL). If levels exceed 700 ng/dL or fall below 400 ng/dL, dose or frequency adjustments are warranted 3.

Critical safety monitoring includes:

  • Hematocrit at baseline, 3-6 months, then annually—therapy must be stopped if hematocrit exceeds 54% 3
  • PSA and digital rectal exam for men over 40 years 3

Practical Storage Note

The vial should maintain sterility throughout the 20-week period if proper technique is used. The FDA label notes that crystals may form during storage at lower temperatures and can be redissolved by warming and shaking 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.